FDA approves single-tablet regimen for HIV-1 infection in treatment-naïve adults
FDA has approved emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Complera, Gilead Sciences), a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults.
FDA approves single-tablet regimen for HIV-1 infection in treatment-naïve adults
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
